Gluformin Combi 100 mg/1000 mg tablete s prilagođenim oslobađanjem
| Name | Gluformin Combi 100 mg/1000 mg tablete s prilagođenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-167742390 |
| Active Substance | sitagliptinklorid hidrat metforminklorid |
| Composition | svaka tableta sadrži 100 mg sitagliptina u obliku sitagliptinklorid hidrata i 1000 mg metforminklorida |
| Pharmaceutical Form | tableta s prilagođenim oslobađanjem |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska
Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka Merckle GmbH, Ulm, Baden – Wuerttemberg, Njemačka |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 11.03.2022 |
| MA Period of Validity | 11.03.2027 |
| Classification Number | UP/I-530-09/20-01/199 |
| Registration Number | 381-12-01/154-22-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BD07 |
| Marketing status | nije stavljeno u promet |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
